Huiyu Pharmaceuticals: Shareholder Huang Ganyi has completed the reduction of 0.68%.

Huiyu Pharmaceutical announced that as of July 16, 2026, shareholder Huang Ganyi's passive reduction plan has been completed. Through centralized bidding, a total of 4.236 million shares of the company were reduced, accounting for 0.68% of the current total share capital of the company. The reduction price ranged from 10.57 to 21.84 yuan per share, with a total reduction amount of 65.2725 million yuan; currently holding 33.0187 million shares, accounting for 5.28%.